Lancashire and South Cumbria
Formulary
Formulary
9 Nutrition and blood
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
09-01-01-01 Oral iron
| Ferrous Fumarate |
|
Formulary
|
Tablets 210mg (equivalent to 69 mg elemental iron), 322mg (equivalent to 106 mg elemental iron) |
|
| Sodium Feredetate |
|
Formulary
|
Sytron® oral solution contains sodium feredetate trihydrate 41.5 mg/mL equivalent to 5.5 mg/mL elemental iron.
Sodifer® oral solution contains sodium feredetate 38 mg/mL equivalent to 5.5 mg/mL elemental iron.
Sodifer® is not suitable for babies under 28 days. |
 Medicines for children: Sodium feredetate for the prevention of anaemia |
|
|
| Ferric maltol |
|
Formulary
|
Iron Deficiency Anaemia in Adult Patients with Inflammatory Bowel Disease. |
 LSCMMG: Ferric Maltol NMR |
|
Links
- LSCMMG: Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement
- LSCMMG: Ferric Maltol NMR
- LSCMMG: Gluten-Free food products: Position Statement
- LSCMMG: Oral Nutritional Supplements in Primary Care
- LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children
- Medicines for children: Sodium feredetate for the prevention of anaemia
- NICE CG32: Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
- NICE NG20: Coeliac disease: recognition, assessment and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE TA743: Crizanlizumab for preventing sickle cell crises in sickle cell disease